ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors with Losses In Excess of $100K to Secure Counsel Before Important Deadline – DECN
The Rosen Law Firm PA
New York, New York, UNITED STATES
NEW YORK, Feb. 14, 2021 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Decision Diagnostics Corp. (OTC: DECN) between March 3, 2020 and December 17, 2020, inclusive (the “Class Period”), of the important
March 16, 2021 lead plaintiff deadline.
SO WHAT: If you purchased Decision Diagnostics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.